Drug interaction study for healthy volunteers
This study checks how a new medicine (NTQ5082) interacts with another drug (midazolam) in healthy people. It helps doctors understand if the new medicine changes how midazolam works, which is important for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You have a body mass index (BMI) between 19.0 and 26.0, and weigh at least 50 kg if male or 45 kg if female.
- You are willing to receive two vaccines (meningococcal and pneumococcal) at least 14 days before the study starts.
- You have not taken any prescription or non-prescription medications, herbal remedies, or supplements within 28 days before the study.
- You do not smoke more than 5 cigarettes a day, and you are willing to stop smoking during the study.
- You are in good health with no major medical conditions, and you are willing to follow strict dietary and lifestyle rules during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This trial tests a new injection called KL0011034 to see if it is safe and how the body processes it. Healthy volunteers aged 18–45 who meet specific health and lifestyle criteria can join.
This trial tests how a new drug (GSK3772701) interacts with another common drug (midazolam) in healthy volunteers. It aims to see if one affects how the other works in the body and will help determine safe dosing for future studies.
This study tests how three drugs (DWP16001, DWC202407, and DWC202408) interact when taken together in healthy adults. It helps make sure the drugs are safe and that there are no unexpected side effects when combined.
This trial tests a new drug called NTQ5082 in healthy people to see how safe it is and how the body processes it. If you qualify, you will help researchers understand the drug's effects before it is tested in patients with a disease.
This trial tests a new medicine, currently known by the code LY4355756, in healthy people to check its safety and how the body handles it. Your participation could help show if this medicine is safe enough to move into larger testing.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.